Company
ChemT Biotechnology
AI-designed approaches for cell state modulation
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- pharma
Claim, correct or request removal
Record updated 18 September 2026
About
We are building the AI layer for CMC (Chemistry, Manufacturing & Controls), one of pharma’s most important yet underserved challenges. Our platform helps pharma better understand the cells behind biologics manufacturing and provides the means to modulate them with precision, enabling faster process development, smoother validation, and lower-cost biologics production.
Funding snapshot
- Total raised
- $5MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Pre seed, $1M
Funding rounds
- Seed
- $4MCompany stated
- Pre seed
- $1MCompany stated
Products
- Other
- CelMo™
- Other
- Chemplify™
Loading relationship preview